Silo Pharma, Inc. (SILO)

Silo Pharma Statistics

Total Valuation

Silo Pharma has a market cap or net worth of $7.58 million. The enterprise value is $1.32 million.

Market Cap	7.58M
Enterprise Value	1.32M

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, after market close.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Silo Pharma has 9.46 million shares outstanding. The number of shares has increased by 64.15% in one year.

Current Share Class	9.46M
Shares Outstanding	9.46M
Shares Change (YoY)	+64.15%
Shares Change (QoQ)	+40.03%
Owned by Insiders (%)	2.14%
Owned by Institutions (%)	4.30%
Float	9.26M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	54.35
Forward PS	n/a
PB Ratio	1.41
P/TBV Ratio	1.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	18.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.07

Current Ratio	6.07
Quick Ratio	5.96
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,019.15

Financial Efficiency

Return on equity (ROE) is -90.03% and return on invested capital (ROIC) is -59.38%.

Return on Equity (ROE)	-90.03%
Return on Assets (ROA)	-43.96%
Return on Invested Capital (ROIC)	-59.38%
Return on Capital Employed (ROCE)	-92.21%
Revenue Per Employee	$24,034
Profits Per Employee	-$1.63M
Employee Count	3
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.21% in the last 52 weeks. The beta is 1.55, so Silo Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.55
52-Week Price Change	-27.21%
50-Day Moving Average	0.65
200-Day Moving Average	0.97
Relative Strength Index (RSI)	66.89
Average Volume (20 Days)	360,571

Short Selling Information

The latest short interest is 67,438, so 0.71% of the outstanding shares have been sold short.

Short Interest	67,438
Short Previous Month	134,766
Short % of Shares Out	0.71%
Short % of Float	0.73%
Short Ratio (days to cover)	0.45

Income Statement

In the last 12 months, Silo Pharma had revenue of $72,102 and -$4.90 million in losses. Loss per share was -$1.00.

Revenue	72,102
Gross Profit	66,264
Operating Income	-5.17M
Pretax Income	-3.60M
Net Income	-4.90M
EBITDA	n/a
EBIT	-5.17M
Loss Per Share	-$1.00

Balance Sheet

The company has $6.26 million in cash and n/a in debt, giving a net cash position of $6.26 million or $0.66 per share.

Cash & Cash Equivalents	6.26M
Total Debt	n/a
Net Cash	6.26M
Net Cash Per Share	$0.66
Equity (Book Value)	4.92M
Book Value Per Share	0.57
Working Capital	5.32M

Cash Flow

Operating Cash Flow	-5.19M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	91.90%
Operating Margin	-7,164.96%
Pretax Margin	-6,789.22%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Silo Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-64.15%
Shareholder Yield	-64.15%
Earnings Yield	-64.62%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 15, 2022. It was a reverse split with a ratio of 1:50.

Last Split Date	Sep 15, 2022
Split Type	Reverse
Split Ratio	1:50

Scores

Silo Pharma has an Altman Z-Score of -3.41 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.41
Piotroski F-Score	2